These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation. Dickmeiss E Scand J Urol Nephrol Suppl; 1977; (42):51-4. PubMed ID: 356222 [TBL] [Abstract][Full Text] [Related]
3. Immunological diagnosis of rejection in human renal allotransplanted patients--a prospective study. Kristensen T; Grunnet N; Hansen HE; Fjeldborg O; Olsen TS; Kissmeyer-Nielsen F Proc Eur Dial Transplant Assoc; 1977; 14():313-20. PubMed ID: 341132 [TBL] [Abstract][Full Text] [Related]
9. Anti-donor immune responses in prediction of transplant rejection. Stiller CR; StC Sinclair NR; Abrahams S; McGirr D; Singh H; Howson WT; Ulan RA N Engl J Med; 1976 Apr; 294(18):978-82. PubMed ID: 130555 [TBL] [Abstract][Full Text] [Related]
10. Monitoring and modulation of recipient immune responsiveness to prevent kidney graft rejection in the early post-transplant period. Renna E; Sansonetti P; Nesci C; Famulari A; Cortesini R Proc Eur Dial Transplant Assoc; 1977; 14():336-41. PubMed ID: 341135 [TBL] [Abstract][Full Text] [Related]
11. Pretransplant assays of alloimmunity in predicting renal graft outcome. Gailiunas P; Person A; Suthanthiran M; Carpenter CB; Garovoy MR Proc Clin Dial Transplant Forum; 1977; 7():1-3. PubMed ID: 356029 [TBL] [Abstract][Full Text] [Related]
12. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470 [TBL] [Abstract][Full Text] [Related]
13. Assessment of whole blood for antibody-dependent cell-mediated cytotoxicity in kidney patients. Dupont E Proc Eur Dial Transplant Assoc; 1977; 14():321-7. PubMed ID: 341133 [TBL] [Abstract][Full Text] [Related]
14. Antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC) in 229 sera from human renal allograft recipients. Descamps B; Gagnon R; van der Gaag R; Feuillet MN; Crosnier J J Clin Lab Immunol; 1979 Nov; 2(4):303-9. PubMed ID: 395307 [TBL] [Abstract][Full Text] [Related]
15. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]